Chemical Structure (Spinosad 01)
Spinosad Suspension
Product Images NDC 84635-570
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Spinosad (NDC 84635-570). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Cipher Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Chemical Structure (Spinosad 02)
Image (Spinosad 03)
Image (Spinosad 04)
Image (Spinosad 05)
Image (Spinosad 06)
Image (Spinosad 07)
Image (Spinosad 08)
Figure A (Spinosad 09)
Figure B (Spinosad 10)
Figure C (Spinosad 11)
Figure D (Spinosad 12)
Figure E (Spinosad 13)
Figure F (Spinosad 14)
Principal Display Panel (120 mL Bottle Carton)
This text provides directions for the use of a topical suspension containing 0.9% w/w of Spinosad. It emphasizes shaking well before use, warns not to swallow, and to keep out of reach of children. It also mentions that the suspension should be used under direct adult supervision on children. In case of eye contact, immediate flushing with water is recommended. If scalp irritation or infection occurs, contact a physician. The text also includes patent information and NDC codes for identification.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
